Our goal in the present study was to evaluate whether
decabromodiphenyl ether (BDE-209), which is the most abundant polybrominated
diphenyl ether (
PBDE) found in human samples, affects against target organs. Sprague-Dawley male rats were exposed to vehicle or
BDE-209 (100, 300, or 600 mg/kg
body weight, daily) from postnatal day (PND) 10 to PND 42. There was no significant difference in body and male reproductive organ weight changes compared with controls. However, liver, thyroid and adrenal gland weights were significantly increased in the high-dose of
BDE-209 group.
BDE-209 significantly induced the expression of
cytochrome P450 (
CYP1A2, CYP3A1, and
CYP2B1)
enzymes in the liver. Furthermore,
constitutive androstane receptor (CAR) and pregnane
xenobiotic receptor (PXR) expression levels were also increased in a dose-dependent manner. Total serum
triiodothyronine (T3) concentration was significantly reduced in a dose-dependent manner, whereas the level of
thyroid-stimulating hormone was significantly increased with
BDE-209 treatment. In the histological findings, multiple areas of degenerated follicular epithelium and slight attenuation of the follicular epithelium were observed in the thyroid glands by high doses (300 and 600 mg/kg) of
BDE-209 treatment. The presence of hepatocytic fatty degeneration and inflammatory foci were also observed in the 300 and 600 mg/kg of
BDE-209 group. These findings demonstrate that
BDE-209 induces
hyperthyroidism and hepatotoxicity. In the future, further research is needed to determine the relationship between target organ toxicity and blood concentrations of
BDE-209.